Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.8K
The pathophysiology of pneumonia involves the following steps:
3.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

999
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
999
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.6K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Impact assessment of telehealth medical nutrition therapy for managing cardiovascular disease risk in rural and remote NSW: the Healthy Rural Hearts study.

Health research policy and systems·2026
Same author

Genomic, proteolytic, and phenotypic characterization of <i>Pseudomonas aeruginosa</i> isolates causing infective endocarditis.

Microbiology spectrum·2026
Same author

Integrating approaches and regulations to address plastic pollution: Spotlighting nanosized particles.

NanoImpact·2026
Same author

Quantifying artificial sweeteners and emulsifiers in Crohn's disease and its relationship with disease activity: the ENIGMA study - a novel and targeted approach.

Gut·2026
Same author

Impact assessment of telehealth medical nutrition therapy for managing cardiovascular disease risk in rural and remote NSW: the Healthy Rural Hearts study.

Health research policy and systems·2026
Same author

Innovative methodologies for elucidating bushfire smoke-induced pathophysiological mechanism.

The Science of the total environment·2026

Related Experiment Video

Updated: Mar 14, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.4K

Emerging pathogenic links between microbiota and the gut-lung axis.

Kurtis F Budden1, Shaan L Gellatly1, David L A Wood2

  • 1Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales 2305, Australia.

Nature Reviews. Microbiology
|November 8, 2016
PubMed
Summary

The gut microbiota influences immune system development and lung health. Dysbiosis, or microbial imbalance, in the gut and respiratory tract is linked to lung diseases, suggesting potential therapeutic targets.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.2K
A Mouse Model of Orotracheal Intubation and Ventilated Lung Ischemia Reperfusion Surgery
09:07

A Mouse Model of Orotracheal Intubation and Ventilated Lung Ischemia Reperfusion Surgery

Published on: September 9, 2022

4.7K

Related Experiment Videos

Last Updated: Mar 14, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.4K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.2K
A Mouse Model of Orotracheal Intubation and Ventilated Lung Ischemia Reperfusion Surgery
09:07

A Mouse Model of Orotracheal Intubation and Ventilated Lung Ischemia Reperfusion Surgery

Published on: September 9, 2022

4.7K

Area of Science:

  • Microbiology
  • Immunology
  • Pulmonology

Background:

  • The human microbiota plays a crucial role in immune system development and maintaining homeostasis.
  • Alterations in microbial composition and function, known as dysbiosis, in the gut and respiratory tract are increasingly associated with immune dysregulation and lung disease.
  • The gut-lung axis, a bidirectional communication pathway, is an emerging area of research connecting these two organ systems.

Purpose of the Study:

  • To review common microbial species in healthy gastrointestinal and respiratory tracts.
  • To discuss the implications of dysbiosis in these sites concerning disease development.
  • To explore the interactions within the gut-lung axis and its potential in treating lung diseases.

Main Methods:

  • Literature review of existing research on respiratory and gut microbiota.
  • Analysis of studies linking microbial dysbiosis to lung pathologies.
  • Synthesis of evidence regarding the gut-lung axis and therapeutic interventions.

Main Results:

  • Identification of key microbial communities in healthy gut and lung environments.
  • Correlation established between specific dysbiotic patterns and the incidence/severity of lung diseases.
  • Emerging evidence supports the gut-lung axis's role in modulating respiratory health.

Conclusions:

  • The gut microbiota significantly impacts immune function and lung homeostasis.
  • Dysbiosis in the gut and respiratory tract is a critical factor in lung disease pathogenesis.
  • Targeting the gut microbiota presents a promising therapeutic strategy for managing lung diseases.